This podcast episode of The Journal discusses the emergence of nitazenes, a synthetic opioid more potent than fentanyl, and its growing impact in Europe. The episode features an interview with Sune Rasmussen, who explains the drug's origins, potency, and the reasons for its increased prevalence in Europe compared to the U.S. The discussion covers how nitazenes are being mixed into other drugs, leading to accidental overdoses, and the ease with which they can be sourced online. It also explores the potential shift of drug suppliers from fentanyl to nitazenes due to regulations in China, and the possible implications for the U.S.
Sign in to continue reading, translating and more.
Continue